GEIGER COUNTER LIMITED Logo

GEIGER COUNTER LIMITED

GCL | IL

Overview

Corporate Details

ISIN(s):
GB00B15FW330 (+1 more)
LEI:
549300O6PWGLLYV1QX57
Country:
Jersey
Address:
Ordnance House, JE4 8PW St Helier
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genedrive PLC develops and commercializes easy-to-use, point-of-care pharmacogenetic tests for improved clinical outcomes. Our tests, such as the CYP2C19 ID Kit and MT-RNR1 ID Kit, are designed for rapid, time-critical settings.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for GEIGER COUNTER LIMITED. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-28 14:53
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-26 17:31
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-22 18:59
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-22 12:26
Fund Information / Factsheet
Monthly Factsheet- July 2025
English 29.7 KB
2025-08-21 14:35
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-20 14:00
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-19 16:23
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-18 15:52
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-15 13:41
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-15 11:50
Transaction in Own Shares
Share Buyback
English 10.4 KB
2025-08-14 13:05
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-14 09:58
Transaction in Own Shares
Share Buyback
English 10.4 KB
2025-08-13 15:36
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-13 11:43
Transaction in Own Shares
Share Buyback
English 10.5 KB
2025-08-12 16:23
Net Asset Value
Net Asset Value(s)
English 11.8 KB

Automate Your Workflow. Get a real-time feed of all GEIGER COUNTER LIMITED filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GEIGER COUNTER LIMITED via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN